These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27714545)

  • 1. Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.
    Usui J; Yamagata K; Imai E; Okuyama H; Kajiyama H; Kanamori H; Kaneko S; Kono E; Sakai Y; Sakai N; Sakamaki Y; Taniguchi Y; Nakai K; Nishiwaki H; Hirata S; Yamaya H; Tsuruoka S; Terada Y; Yokoyama H; Wada T; Narita I
    Clin Exp Nephrol; 2016 Dec; 20(6):827-831. PubMed ID: 27714545
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrologists Sans Frontières: chronic kidney disease in Japan.
    Sasaki S
    Kidney Int; 2006 May; 69(9):1485-6. PubMed ID: 16652161
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practice guidelines for drug-induced kidney disease 2016].
    Nihon Jinzo Gakkai Shi; 2016; 58(4):477-555. PubMed ID: 27416697
    [No Abstract]   [Full Text] [Related]  

  • 4. KHA-CARI Guideline recommendations for renal biopsy.
    MacGinley R; Champion De Crespigny PJ; Gutman T; Lopez-Vargas P; Manera K; Menahem S; Saunders J; See E; Voss D; Wong J
    Nephrology (Carlton); 2019 Dec; 24(12):1205-1213. PubMed ID: 31490584
    [No Abstract]   [Full Text] [Related]  

  • 5. The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.
    Friedewald VE; Goldfarb S; Laskey WK; Vetrovec GW; Roberts WC
    Am J Cardiol; 2011 Jun; 107(12):1848-55. PubMed ID: 21640219
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.
    Johnson CA; Levey AS; Coresh J; Levin A; Lau J; Eknoyan G
    Am Fam Physician; 2004 Sep; 70(6):1091-7. PubMed ID: 15456118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.
    Yokoyama H; Narita I; Sugiyama H; Nagata M; Sato H; Ueda Y; Matsuo S
    Clin Exp Nephrol; 2016 Oct; 20(5):720-730. PubMed ID: 26590949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of drug induced nephropathy].
    Ueda S
    Nihon Jinzo Gakkai Shi; 2012; 54(7):950-7. PubMed ID: 23234204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Review of the clinical practice guidebook for diagnosis and treatment of chronic kidney disease].
    Uchida S
    Nihon Rinsho; 2008 Sep; 66(9):1803-6. PubMed ID: 18788413
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to the article by Lynn et al: older patients in the nephrology clinic--should they be referred?
    Endre Z
    N Z Med J; 2006 Apr; 119(1232):U1941. PubMed ID: 16633399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guidelines for handling and assessment of renal biopsy specimens: Brief report from the committee for standardization of renal pathology diagnosis, JSN].
    Makino H; Shigematsu H; Joh K; Taguchi T; Saito T; Nishi S; Matsuo S; Yokoyama H; Hattori M; Honda M; Yoshikawa N
    Nihon Jinzo Gakkai Shi; 2004; 46(8):747-80. PubMed ID: 15645732
    [No Abstract]   [Full Text] [Related]  

  • 12. The Native Kidney Biopsy: Update and Evidence for Best Practice.
    Hogan JJ; Mocanu M; Berns JS
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):354-62. PubMed ID: 26339068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Renal Best Practice Advisory Board's dialysis initiation guidelines: one size won't fit all.
    Rosansky SJ
    Kidney Int; 2011 Nov; 80(10):1005-7. PubMed ID: 22042024
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine reporting of estimated glomerular filtration rate: not ready for prime time.
    Glassock RJ; Winearls CG
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):422-3. PubMed ID: 18594501
    [No Abstract]   [Full Text] [Related]  

  • 15. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
    Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group
    Kidney Int; 2021 Oct; 100(4S):S1-S276. PubMed ID: 34556256
    [No Abstract]   [Full Text] [Related]  

  • 16. [Positioning of CKD in risk stratification].
    Ito S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):461-4. PubMed ID: 19601554
    [No Abstract]   [Full Text] [Related]  

  • 17. Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing.
    Kagoma YK; Garg AX; Li L; Jain AK
    Kidney Int; 2012 Jun; 81(12):1245-7. PubMed ID: 22336989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced nephropathy].
    Shimizu H; Tanaka A; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():549-53. PubMed ID: 18074600
    [No Abstract]   [Full Text] [Related]  

  • 19. On being better kidney doctors: understanding trajectories, probabilities, predictability, and people.
    Levin A; Djurdjev O
    Am J Kidney Dis; 2012 Apr; 59(4):475-7. PubMed ID: 22444489
    [No Abstract]   [Full Text] [Related]  

  • 20. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.